Wave Life Sciences (NASDAQ:WVE) Coverage Initiated at Wells Fargo & Company

Wells Fargo & Company started coverage on shares of Wave Life Sciences (NASDAQ:WVE – Free Report) in a report released on Wednesday, MarketBeat.com reports. The firm issued an overweight rating and a $11.00 price target on the stock. Other analysts have also recently issued research reports about the stock. StockNews.com cut shares of Wave Life […]

Related Keywords

Switzerland ,Canada ,Swiss ,Kyle Moran ,Royal Bank ,Swiss National Bank ,Securities Exchange Commission ,Jamesj Burns Company ,Ameritas Investment Partners Inc ,Capstone Investment Advisors ,Wells Fargo Company ,Wave Life Sciences ,Analyst Recommendations For Wave Life Sciences ,Wave Life Sciences Company Profile ,News Ratings For Wave Life Sciences Daily ,Wave Life Sciences Stock Performance ,Institutional Trading Of Wave Life Sciences ,Wave Life Sciences Ltd ,Proshare Advisors ,Wells Fargo ,Free Report ,Truist Financial ,Moderate Buy ,Life Sciences ,Get Free Report ,Exchange Commission ,Wave Life ,Investment Partners ,National Bank ,Investment Advisors ,Share Advisors ,Life Sciences Ltd ,Wave Life Sciences Daily ,